Ncyte® vCardiomyocytes
Human iPSC-derived ventricular-like cardiomyocytes
Ventricular cardiomyocytes generated with our standardized process are fully functional. Their relatively slow beat rate enables pacing for electrophysiological research. Base on this model, an array of functional assays can be developed and optimized providing relevant predictions of drug-induced responses.
Our team can generate cardiomyocytes from the iPSC that best fits your project or work with off-the-shelf Ncyte® vCardiomyocytes to support your projects.
- High purity ventricular-like cardiomyocytes
- Physiologically relevant
- Highly suitable for electrophysiological research
Do you want to buy Ncyte® vCardiomyocytes?
Do you need a custom cell model?
Product Specifications
Identity markers
≥ 70% TNNT2 at day 3 of culture according user guide
Size
≥ 4M viable cells at day 3 of culture according to user guide
Quality Control
Cell count, Viability, Identity (FACS), Functionality (MEA), Mycoplasma
Format
Cryopreserved cells
Donor
Female
Reprogramming method
Non-viral
Shipping conditions
Dry shipper, -180°C to -135°C
Storage conditions
Vapor phase of liquid nitrogen
Supplied with
Ncyte® Cardiomyocyte Medium
Technical Data
Ncyte® vCardiomyocytes are characterized by flow cytometry to ensure a purity of ≥ 70% cardiac TroponinT (cTnT) positive cells after 3 days in culture following Ncardia’s user guide (Figure 2A). They typically express Myosin Light Chain 2v (MLC2v), indicating a ventricular-like phenotype (Figure 2B). Based on RNA-seq data, Ncyte® vCardiomyocytes express common sarcomere markers, such as TNNT2, while hiPSC and cardiac progenitor markers are silenced. Expression levels of additional genes are available upon request.
Ncyte® vCardiomyocytes exhibit well aligned myofibrils and intact structural sarcomere organization (See figure A). They typically express Myosin Light Chain 2v (MLC2v), indicating a ventricularlike phenotype. Based on RNA-seq data, Ncyte® vCardiomyocytes express common sarcomere markers, such as TNNT2, while hiPSC and cardiac progenitor markers are silenced. Expression levels of additional genes are available upon request.
Their action potential shows fast upstroke velocity and a well-defined plateau phase, resembling human ventricular cardiomyocytes (See figure B).
These make the Ncyte® vCardiomyocytes a physiologically relevant model for the phenotypic study of cardiac diseases. Our expert scientists can develop and execute predictive assays to support your drug discovery research in the cardiac field.
Ncyte® vCardiomyocytes present a relatively slow and uniform beating rate, which enables pacing for electrophysiological research (See top figure). Additionally, response to adrenergic stimulation with isoproterenol and ion channel blockers, nifedipine (L-type calcium channel blocker) and dofetilide (hERG channel blocker), is guaranteed for every batch (See figure A, B, C). Our scientific team is experienced in the electrophysiological analysis of Ncyte® vCardiomyocytes for safety and efficacy studies and can report the analyzed results to you.
Certificates of analysis are available upon request via support@ncardia.com
Our work centers on a simple yet powerful premise:
When we combine deep iPSC knowledge, broad assay capabilities and a demonstrated ability to integrate the biology of human diseases into preclinical research, we can help drug developers make critical decisions earlier and with more confidence.
Human iPSC-derived atrial cardiomyocytes
Neural Cortical NeuronsHuman iPSC-derived cortical neurons
Neural Ncyte® AstrocytesHuman iPSC-derived astrocytes
Vascular Ncyte® Endothelial cellsHuman iPSC-derived vascular endothelial cells
Neural Ncyte® Neural MixHuman iPSC-derived neurons and astrocytes
Cardiac Ncyte® vCardiomyocytesHuman iPSC-derived ventricular cardiomyocytes
Neural Peripheral NeuronsHuman iPSC-derived peripheral neurons
Vascular Vascular Smooth Muscle cellsHuman iPSC-derived vascular smooth muscle cells